Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics
5 July 2016
“Complementary diagnostics” are defined as tests using biomarkers for risk assessment, diagnosis, prognosis, monitoring, and guiding therapeutic decisions. This White Paper presents a more comprehensive framework for considering their value contribution.
Age, Utilities, and Self-Reported Health: Issues for HTA
28 June 2016
On Wednesday 18th May OHE’s Patricia Cubi-Molla presented an OHE Lunchtime Seminar on age, utilities and self-reported health. This post contains a short summary and the…
OHE at ISPOR Washington DC (2): EQ-5D and Valuing Health Gains.
10 June 2016
This is part two of two posts containing posters and presentations by members of the OHE team at ISPOR’s 21st Annual International Meeting held in Washington…
OHE at ISPOR Washington DC (1): HTA, Evidence and Pricing
9 June 2016
This is part one of two posts containing posters and presentations by members of the OHE team at ISPOR’s 21st Annual International Meeting held in Washington…
What Drives Variations in Relative Effectiveness Across Countries?
31 May 2016
This study provides an analytical framework, drawing on production function theory, to identify and quantify the determinants of relative effectiveness and sources of variation in the…
OHE Posters at HTAi: Tokyo 2016
24 May 2016
This post contains posters which were presented by members of the OHE team at the 2016 HTAi Annual Meeting held in Tokyo, Japan, 10-14 May.
OHE Presentations at HTAi: Tokyo 2016
24 May 2016
The 2016 HTAi Annual Meeting was held in Tokyo, Japan, 10-14 May 2016. The focus of the meeting was Informing Health Care Decisions with Values and…
OHE at ISPOR May 2016: Meet the Team
19 May 2016
ISPOR’s 21st Annual International Meeting is scheduled for 20-25th May 2016 in Washington DC. Several members of the OHE team will be attending and disseminating important…
OHE at ISPOR Italy Chapter – Rome: Are Wider Societal Effects Considered in Healthcare Decision-making?
17 May 2016
Martina Garau presented at the last ISPOR Italy Chapter – Rome conference on the topic of economic gains produced by health interventions.